Dexcom (DXCM) Share-based Compensation Growth (1y) (2011 - 2025)
Dexcom (DXCM) Share-based Compensation Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -30.44% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 59.09% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 31.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19.17% |
| Sep 30, 2025 | 3.92% |
| Jun 30, 2025 | 77.85% |
| Dec 31, 2024 | 17.34% |
| Sep 30, 2024 | 11.28% |
| Jun 30, 2024 | 12.59% |
| Mar 31, 2024 | 10.80% |
| Dec 31, 2023 | 8.53% |
| Sep 30, 2023 | 26.62% |
| Jun 30, 2023 | 21.78% |
| Mar 31, 2023 | 20.96% |
| Dec 31, 2022 | 29.28% |
| Sep 30, 2022 | -59.84% |
| Jun 30, 2022 | 6,420.00% |
| Mar 31, 2022 | 193.94% |
| Dec 31, 2021 | -22.87% |
| Sep 30, 2021 | 149.84% |
| Jun 30, 2021 | -98.37% |
| Mar 31, 2021 | -58.58% |
| Dec 31, 2020 | 44.49% |